These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 26691659)

  • 1. The Cost Effectiveness of High-Dose versus Conventional Haemodialysis: a Systematic Review.
    Laplante S; Liu FX; Culleton B; Bernardo A; King D; Hudson P
    Appl Health Econ Health Policy; 2016 Apr; 14(2):185-93. PubMed ID: 26691659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of haemodialysis and peritoneal dialysis for patients with end-stage renal disease in Singapore.
    Yang F; Lau T; Luo N
    Nephrology (Carlton); 2016 Aug; 21(8):669-77. PubMed ID: 26566750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose hemodialysis versus conventional in-center hemodialysis: a cost-utility analysis from a UK payer perspective.
    Liu FX; Treharne C; Arici M; Crowe L; Culleton B
    Value Health; 2015 Jan; 18(1):17-24. PubMed ID: 25595230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-Effectiveness of High Dose Hemodialysis in Comparison to Conventional In-Center Hemodialysis in the Netherlands.
    Beby AT; Cornelis T; Zinck R; Liu FX
    Adv Ther; 2016 Nov; 33(11):2032-2048. PubMed ID: 27664108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lifetime cost-effectiveness analysis of first-line dialysis modalities for patients with end-stage renal disease under peritoneal dialysis first policy.
    Wong CKH; Chen J; Fung SKS; Mok M; Cheng YL; Kong I; Lo WK; Lui SL; Chan TM; Lam CLK
    BMC Nephrol; 2020 Feb; 21(1):42. PubMed ID: 32019528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct and indirect costs of end-stage renal disease patients in the first and second years after initiation of nocturnal home haemodialysis, hospital haemodialysis and peritoneal dialysis.
    Wong CKH; Chen J; Fung SKS; Mok MMY; Cheng YL; Kong I; Lo WK; Lui SL; Chan TM; Lam CLK
    Nephrol Dial Transplant; 2019 Sep; 34(9):1565-1576. PubMed ID: 30668781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Healthcare systems and end-stage renal disease (ESRD) therapies--an international review: costs and reimbursement/funding of ESRD therapies.
    De Vecchi AF; Dratwa M; Wiedemann ME
    Nephrol Dial Transplant; 1999; 14 Suppl 6():31-41. PubMed ID: 10528710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost Effectiveness of Dialysis Modalities: A Systematic Review of Economic Evaluations.
    Howell M; Walker RC; Howard K
    Appl Health Econ Health Policy; 2019 Jun; 17(3):315-330. PubMed ID: 30714086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cost-effectiveness of contemporary home haemodialysis modalities compared with facility haemodialysis: a systematic review of full economic evaluations.
    Walker R; Marshall MR; Morton RL; McFarlane P; Howard K
    Nephrology (Carlton); 2014 Aug; 19(8):459-70. PubMed ID: 24750559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodialysis for end-stage renal disease: a cost-effectiveness analysis of treatment-options.
    Gonzalez-Perez JG; Vale L; Stearns SC; Wordsworth S
    Int J Technol Assess Health Care; 2005; 21(1):32-9. PubMed ID: 15736512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Financial implications of dialysis modalities in the developing world: A Chinese perspective.
    Liu J; Hutton DW; Gu Y; Hu Y; Li Y; Ma L; Zeng X; Fu P
    Perit Dial Int; 2020 Mar; 40(2):193-201. PubMed ID: 32063196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The financial impact of increasing home-based high dose haemodialysis and peritoneal dialysis.
    Liu FX; Treharne C; Culleton B; Crowe L; Arici M
    BMC Nephrol; 2014 Oct; 15():161. PubMed ID: 25278356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-Effectiveness Analysis of High-Efficiency Hemodiafiltration Versus Low-Flux Hemodialysis Based on the Canadian Arm of the CONTRAST Study.
    Lévesque R; Marcelli D; Cardinal H; Caron ML; Grooteman MP; Bots ML; Blankestijn PJ; Nubé MJ; Grassmann A; Canaud B; Gandjour A
    Appl Health Econ Health Policy; 2015 Dec; 13(6):647-59. PubMed ID: 26071951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic evaluation of palliative management versus peritoneal dialysis and hemodialysis for end-stage renal disease: evidence for coverage decisions in Thailand.
    Teerawattananon Y; Mugford M; Tangcharoensathien V
    Value Health; 2007; 10(1):61-72. PubMed ID: 17261117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cost-utility of haemodiafiltration versus haemodialysis in the Convective Transport Study.
    Mazairac AH; Blankestijn PJ; Grooteman MP; Penne EL; van der Weerd NC; den Hoedt CH; Buskens E; van den Dorpel MA; ter Wee PM; Nubé MJ; Bots ML; de Wit GA;
    Nephrol Dial Transplant; 2013 Jul; 28(7):1865-73. PubMed ID: 23766337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.
    Picot J; Jones J; Colquitt JL; Gospodarevskaya E; Loveman E; Baxter L; Clegg AJ
    Health Technol Assess; 2009 Sep; 13(41):1-190, 215-357, iii-iv. PubMed ID: 19726018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost comparison of peritoneal dialysis versus hemodialysis in end-stage renal disease.
    Berger A; Edelsberg J; Inglese GW; Bhattacharyya SK; Oster G
    Am J Manag Care; 2009 Aug; 15(8):509-18. PubMed ID: 19670954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Cost-Effectiveness of Kidney Replacement Therapy Modalities: A Systematic Review of Full Economic Evaluations.
    Yang F; Liao M; Wang P; Yang Z; Liu Y
    Appl Health Econ Health Policy; 2021 Mar; 19(2):163-180. PubMed ID: 33047212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic evaluation of centre haemodialysis and continuous ambulatory peritoneal dialysis in Ministry of Health hospitals, Malaysia.
    Hooi LS; Lim TO; Goh A; Wong HS; Tan CC; Ahmad G; Morad Z
    Nephrology (Carlton); 2005 Feb; 10(1):25-32. PubMed ID: 15705178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensive Hemodialysis and Mortality Risk in Australian and New Zealand Populations.
    Marshall MR; Polkinghorne KR; Kerr PG; Hawley CM; Agar JW; McDonald SP
    Am J Kidney Dis; 2016 Apr; 67(4):617-28. PubMed ID: 26561355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.